Business
Press Release May 02 2025
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 02, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Ticagrelor Tablets, 90 mg and Tentative Approval for Ticagrelor Tablets, 60 mg".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 02, 2025, titled \"Alembic Pharmaceuticals Limited receives USFDA Final Approval for Ticagrelor Tablets, 90 mg and Tentative Approval for Ticagrelor Tablets, 60 mg\". View Attachment","length":432,"tagName":"div"}]